Assessing the outcome

What an approval establishes

The European Commission approved Interpump as a suitable purchaser and found the proposed agreement consistent with the commitments. Paragraph 59 expressly separated that approval from confirmation of Danfoss’s compliance. That is a reason to examine implementation records. It is not a finding of noncompliance. Purchaser approval, paragraphs 57–59

White’s reported commercial performance

In its May 15, 2023 presentation, Interpump reported White Drive sales growth of almost 28% and an EBITDA margin above 21% in the first quarter of 2023. This is affirmative management-reported evidence of commercial progress at that point. Interpump Q1 2023 results, slide 6 / PDF page 7

Our analysis treats those results as evidence to test alongside customer outcomes. Growth and profitability can support a business’s ability to invest, but they do not independently establish the price, delivery, quality, or alternatives available to a particular U.S. customer. The reporting period matters: these figures describe Q1 2023.

The Hopkinsville investment

Kentucky’s February 2023 announcement described nearly US$16 million of planned investment,25 full-time jobs, and a transfer of gearset production from Parchim to Hopkinsville. This is material evidence of an investment plan directed toward U.S. manufacturing capability. Kentucky expansion announcement

Our analysis gives that announcement weight while asking the next questions: what equipment was installed, when production was qualified, what output became available, and whether the jobs and investment targets were met. The announcement alone cannot answer those questions or establish market-wide pricing and service outcomes.

Separate the tests

The test framework is our analysis. The case’s purpose and market concerns are documented in the DOJ announcement.

What would support a causal conclusion?

An extended lead time is an observation. Showing that the remedy’s implementation caused it requires a product-level chronology: the prior source, transfer milestone, order requirement, available stock, alternative supply, and the event that changed delivery. The comparison also needs to account for demand, material shortages, design changes, and other explanations.

The same discipline applies to price, quality, and lost business. A program moving to another supplier may show competition working, a service problem, a redesign, or a strategic sourcing decision. The reason and surrounding evidence matter. A single account cannot establish the condition of the whole market.

Company-wide revenue and profit provide context, but they do not isolate a particular White product family, U.S. customer group, or plant. A credible assessment needs a level of detail that matches the claim.

Questions for continued reporting

1. Which transferred product lines became operational, on what dates, and at what qualified capacity?
2. What transition issues were identified, corrected, or accepted by the responsible regulators?
3. What did the monitoring trustees report, and on what basis did their work conclude or continue?
4. How did U.S. customers’ effective supply options, service, and commercial terms change?
5. What evidence would DOJ rely on for an early-termination notice, if one is issued?

These questions keep the investigation open to findings of effective implementation, mixed results, or failure supported by evidence. The public documents reviewed here establish the design of the remedy and selected later developments; they do not resolve every outcome question.